Two new analyses, one from France and one from China, suggest that seasonal influenza vaccination provided moderate protection during the early months of the 2025–26 flu season, despite the rapid ...
The preventive immunization Nous-209 works in an initial trial with patients who have 17 times the risk of developing tumors ...
Researchers at Penn Medicine have developed an mRNA vaccine that could potentially cure allergies by stopping allergens from ...
An LMU research team led by Professor Olivia M. Merkel, Chair of Drug Delivery at LMU, has developed a new delivery system ...
Neoantigens are unique markers that distinguish only cancer cells. By adding B cell reactivity, cancer vaccines can move beyond one-time attacks and short-term memory to become a long-term immunity ...
Novel hybrid polymer nanocarriers enable effective vaccine delivery in the lungs and the targeted activation of immune cells.
A controversial Hepatitis B vaccine safety trial will go on as planned in Africa, amid concerns over its ethics and design ...
The government of Pakistan is moving to strengthen the country’s healthcare system by promoting domestic vaccine ...
The government has finalised a draft national policy to promote local vaccine manufacturing, offering 10-year financial ...
A future ASF vaccination program must be accompanied by an accurate way to distinguish vaccinated animals from those ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback